Gamma probe developer Neoprobe has signed an agreement with Johnson & Johnson’s Ethicon Endo-Surgery division for sales and marketing of Neoprobe 1500, a portable radioisotope detector recently released by Neoprobe. Ethicon Endo-Surgery of
Gamma probe developer Neoprobe has signed an agreement with Johnson & Johnsons Ethicon Endo-Surgery division for sales and marketing of Neoprobe 1500, a portable radioisotope detector recently released by Neoprobe. Ethicon Endo-Surgery of Cincinnati, OH, will have rights to promote Neoprobe 1500 and its reusable probes for one year in the U.S., and the two companies are in discussions over extending the deal to cover Europe, Japan, and Australia. Neoprobe of Dublin, OH, previously had an agreement with U.S. Surgical, but that deal broke down last year.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.